Kairos Long Short Equity Strategy Series 569 Notes due 2045 XS3238271764
95.82
USD
0.00
USD
0.00
%
31.7.2026
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 95.82 USD | USD | % |
|---|
| Vortag | USD | Datum | 31.07.2026 |
Anzeige
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Ethena ETP | CH1506167035 | 92.05% | |
| 21Shares Aave ETP | CH1135202120 | 54.03% | |
| 21Shares Uniswap ETP | CH1135202096 | 53.39% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 33.05% | |
| 21Shares Chainlink ETP | CH1100083471 | 32.44% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 31.70% | |
| 21Shares Jupiter ETP | CH1480821383 | 30.86% | |
| 21Shares Pendle ETP | CH1495416997 | 25.87% | |
| 21Shares Maple Finance ETP | CH1495416989 | 12.45% | |
| 21shares Strategy Yield ETP USD | CH1528107811 | 1.67% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 194.52% | |
| 21Shares Injective Staking ETP | CH1360612134 | 71.30% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 69.27% | |
| 21shares Ethena ETP | CH1506167035 | 56.69% | |
| 21Shares Jupiter ETP | CH1480821383 | 50.68% | |
| 21Shares Ondo ETP | CH1396389921 | 40.49% | |
| 21shares Morpho ETP | CH1506167027 | 36.49% | |
| 21Shares Pendle ETP | CH1495416997 | 35.67% | |
| 21Shares Bittensor ETP | CH1495416971 | 34.58% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 30.45% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 85.54% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 13.93% | |
| 21Shares Binance BNB ETP | CH0496454155 | -20.08% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -24.12% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -26.99% | |
| 21Shares Injective Staking ETP | CH1360612134 | -59.25% | |
| 21Shares Dogecoin ETP | CH1431521033 | -59.93% | |
| 21Shares XDC Network ETP | CH1464217285 | -63.89% | |
| 21Shares Sui Staking ETP | CH1360612159 | -76.93% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -78.71% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 136.96% | |
| 21Shares Stellar ETP | CH1109575535 | 85.01% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 69.52% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 61.14% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 29.60% | |
| 21Shares Sui Staking ETP | CH1360612159 | -10.75% | |
| 21Shares Injective Staking ETP | CH1360612134 | -71.83% |
Fundamentaldaten
| Valor | |
| ISIN | XS3238271764 |
| Emittent | Alveo Wealth Management LLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 28.11.2025 |
| Kategorie | Aktien Long/Short Sonstige |
| Währung | USD |
| Volumen | |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 05.08.2026 |
Anlagepolitik
So investiert der Kairos Long Short Equity Strategy Series 569 Notes due 2045: "The Investment Strategy deploys a bottom-up fundamental approach to security selection, taking concentrated directional positions, both long and short, primarily in public equity securities that trade on US stock exchanges with a medium to long-term outlook. A factor-based quantitative overlay strategy may be implemented to control systematic exposures from common relationships between securities."
ETP Performance: Kairos Long Short Equity Strategy Series 569 Notes due 2045
| Performance 1 Jahr | - | |
| Performance 2 Jahre | - | |
| Performance 3 Jahre | - | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |